loadpatents
name:-0.052573919296265
name:-0.013161897659302
name:-0.0035181045532227
Lenz; Heinz-Josef Patent Filings

Lenz; Heinz-Josef

Patent Applications and Registrations

Patent applications and USPTO patent grants for Lenz; Heinz-Josef.The latest application filed is for "hent1 plus mate1/oct2 polymorphisms predict efficacy and toxicity of tas-102 in metastatic colorectal cancer patients".

Company Profile
4.15.54
  • Lenz; Heinz-Josef - Los Angeles CA
  • Lenz; Heinz-Josef - Altadena CA US
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Polymorphism biomarkers predict clinical outcomes of cancer patients receiving regorafenib
Grant 10,563,267 - Lenz Feb
2020-02-18
Hent1 Plus Mate1/oct2 Polymorphisms Predict Efficacy And Toxicity Of Tas-102 In Metastatic Colorectal Cancer Patients
App 20190233884 - Lenz; Heinz-Josef
2019-08-01
Polymorphisms Toll Like Receptor Genes Predicts Clinical Outcomes Of Colorectal Cancer Patients
App 20190161803 - Lenz; Heinz-Josef
2019-05-30
Polymorphisms In Cachexia Predict Clinical Outcomes Of Colorectal Cancer Patients Receiving Irinotecan And Bevacizumab
App 20180311347 - Lenz; Heinz-Josef
2018-11-01
Polymorphism Biomarkers Predict Clinical Outcomes Of Cancer Patients Receiving Regorafenib
App 20170369949 - Lenz; Heinz-Josef
2017-12-28
Polymorphisms In Angiogenesis Pathway Genes Associated With Tumor Recurrence In Surgery Treated Cancer Patients
App 20140005064 - Lenz; Heinz-Josef
2014-01-02
EGFR polymorphisms predict gender-related treatment
Grant 8,568,968 - Lenz October 29, 2
2013-10-29
Polymorphisms For Predicting Disease And Treatment Outcome
App 20130196955 - Lenz; Heinz-Josef ;   et al.
2013-08-01
Gene polymorphisms predictive for dual TKI therapy
Grant 8,435,752 - Lenz May 7, 2
2013-05-07
Cancer Stem Cell Gene Variants Are Associated With Tumor Recurrence
App 20130023430 - Lenz; Heinz-Josef
2013-01-24
Genetic markers for predicting responsiveness to combination therapy
Grant 8,357,369 - Lenz January 22, 2
2013-01-22
Polymorphisms in voltage-gated sodium channel alpha 1-subunit as markers for therapy selection
Grant 8,318,426 - Lenz November 27, 2
2012-11-27
Igf1r Polymorphism Predicts Tumor Recurrence In Breast Cancer Patients
App 20120289424 - Lenz; Heinz-Josef ;   et al.
2012-11-15
Ercc1 Gene Expression Level Is Associated With Clinical Outcomes In Esophageal Cancer Patients
App 20120289592 - Lenz; Heinz-Josef
2012-11-15
Germline Polymorphisms In The Sparc Gene Associated With Clinical Outcome In Gastric Cancer
App 20120288861 - Lenz; Heinz-Josef
2012-11-15
Genetic Variant In Formyl Peptide Receptor 2 (fpr2) Predicts Clinical Outcome In Cancer Patients
App 20120289410 - Lenz; Heinz-Josef ;   et al.
2012-11-15
Polymorphisms in the EGFR pathway as markers for cancer treatment
Grant 8,278,061 - Lenz , et al. October 2, 2
2012-10-02
Gene polymorphisms as predictors of tumor progression and their use in cancer therapy
Grant 8,216,781 - Lenz , et al. July 10, 2
2012-07-10
Genomic Polymorphism For Predicting Therapeutic Response
App 20120129178 - Lenz; Heinz-Josef ;   et al.
2012-05-24
Polymorphisms For Predicting Disease And Treatment Outcome
App 20120122946 - LENZ; Heinz-Josef ;   et al.
2012-05-17
Vegf And Vegfr1 Gene Expression Useful For Cancer Prognosis
App 20120108445 - Lenz; Heinz-Josef
2012-05-03
Polymorphisms In Angiogenesis Pathway Genes Associated With Tumor Recurrence In Surgery Treated Cancer Patients
App 20120108441 - Lenz; Heinz-Josef
2012-05-03
Polymorphism In K-ras 3' Untranslated Region Associated With Clinical Outcomes Of Cancer Treatments Independent Of K-ras Mutation Status
App 20120107309 - Lenz; Heinz-Josef
2012-05-03
Gene Expression Levels Of Egfr, Vegfr2, And Ercc1 Associated With Clinical Outcomes Of Chemotherapy
App 20120107308 - Lenz; Heinz-Josef
2012-05-03
Genetic Variants In Angiogenesis Pathway Associated With Clinical Outcome
App 20120100134 - Lenz; Heinz-Josef
2012-04-26
Cd133 Polymorphisms And Expression Predict Clinical Outcome In Patients With Cancer
App 20120100997 - Lenz; Heinz-Josef
2012-04-26
Genetic Polymorphisms Associated With Clinical Outcomes Of Topoisomerase Inhibitor Therapy For Cancer
App 20120100135 - LENZ; Heinz-Josef
2012-04-26
FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
App 20120094291 - LENZ; Heinz-Josef
2012-04-19
Genetic Variants In Il-6, P53, Mmp-9 And Cxcr Predict Clinical Outcome In Patients With Cancer
App 20120094844 - Lenz; Heinz-Josef
2012-04-19
Intratumoral Gene Expression Levels Of Tp And Vegf Are Associated With Clinical Outcomes In Rectal Cancer Patients Treated With 5-fluorouracil And Pelvic Radiation
App 20120077685 - Lenz; Heinz-Josef
2012-03-29
Genetic Markers for Predicting Responsiveness to Combination Therapy
App 20120020984 - Lenz; Heinz-Josef
2012-01-26
Genotype and Expression Analysis for Use in Predicting Outcome and Therapy Selection
App 20110178110 - Lenz; Heinz-Josef ;   et al.
2011-07-21
Thymidylate Synthase Haplotype is Associated with Tumor Recurrence in Stage II and Stage III Colon Cancer Patients
App 20110160216 - Lenz; Heinz-Josef
2011-06-30
ERCC-1 Gene Expression Predicts Chemotherapy Outcome
App 20110105529 - Lenz; Heinz-Josef
2011-05-05
Angiogenesis Pathway Gene Polymorphisms for Therapy Selection
App 20110020333 - LENZ; Heinz-Josef
2011-01-27
Egfr Polymorphisms Predict Gender-related Treatment
App 20100286179 - LENZ; Heinz-Josef
2010-11-11
Angiogenesis pathway gene polymorphisms for therapy selection
Grant 7,807,364 - Lenz October 5, 2
2010-10-05
Genetic Markers for Predicting Disease and Treatment Outcome
App 20100233719 - LENZ; HEINZ-JOSEF
2010-09-16
Polymorphisms in Voltage-Gated Sodium Channel Alpha 1-Subunit as Markers for Therapy Selection
App 20100216826 - Lenz; Heinz-Josef
2010-08-26
Germline Polymorphisms in the Angiogenic Pathway Predict Tumor Recurrence in Cancer Therapy
App 20100184773 - Lenz; Heinz-Josef
2010-07-22
Gene Polymorphisms Predictive for Dual TKI Therapy
App 20100183593 - Lenz; Heinz-Josef
2010-07-22
Polymorphisms in the EGFR Pathway as Markers for Cancer Treatment
App 20100172901 - Lenz; Heinz-Josef ;   et al.
2010-07-08
Polymorphisms for Predicting Disease and Treatment Outcome
App 20100173922 - Lenz; Heinz-Josef ;   et al.
2010-07-08
Tissue Factor Promoter Polymorphisms
App 20100152202 - Lenz; Heinz-Josef
2010-06-17
Polymorphisms in voltage-gated sodium channel .alpha. 1-subunit as markers for therapy selection
Grant 7,727,724 - Lenz June 1, 2
2010-06-01
Gene Polymorphisms as Predictors of Tumor Progression and Their Use in Cancer Therapy
App 20100113459 - Lenz; Heinz-Josef ;   et al.
2010-05-06
Gene Polymorphisms in VEGF and VEGF Receptor 2 as Markers for Cancer Therapy
App 20100104583 - Lenz; Heinz-Josef
2010-04-29
Gene Polymorphisms as Sex-Specific Predictors in Cancer Therapy
App 20100099720 - Lenz; Heinz-Josef ;   et al.
2010-04-22
Genetic Markers for Predicting Responsiveness to Combination Therapy
App 20100092485 - Lenz; Heinz-Josef
2010-04-15
Polymorphisms in the ERCC1 gene for predicting treatment outcome
Grant 7,662,553 - Lenz , et al. February 16, 2
2010-02-16
FCgamma POLYMORPHISMS FOR PREDICTING DISEASE AND TREATMENT OUTCOME
App 20090181016 - Lenz; Heinz-Josef
2009-07-16
Genomic Polymorphism For Predicting Therapeutic Response
App 20080286789 - Lenz; Heinz-Josef ;   et al.
2008-11-20
Polymorphisms In Voltage-gated Sodium Channel Alpha 1-subunit As Markers For Therapy Selection
App 20070244083 - LENZ; Heinz-Josef
2007-10-18
Genetic Markers For Predicting Disease And Treatment Outcome
App 20070218487 - Lenz; Heinz-Josef
2007-09-20
Angiogenesis Pathway Gene Polymorphisms For Therapy Selection
App 20070207486 - Lenz; Heinz-Josef
2007-09-06
Genetic markers for predicting disease and treatment outcome
App 20060115827 - Lenz; Heinz-Josef
2006-06-01
Polymorphisms for predicting disease and treatment outcome
App 20060094012 - Lenz; Heinz-Josef ;   et al.
2006-05-04
Thymidylate synthase polymorphisms for use in screening for cancer susceptibility
App 20060051764 - Mandola; Michael ;   et al.
2006-03-09
Manganese superoxide dismutase gene polymorphism for predicting cancer susceptibility
App 20040067519 - Lenz, Heinz-Josef ;   et al.
2004-04-08
Manganese superoxide dismutase gene polymorphism for predicting cancer susceptibility
Grant 6,716,581 - Lenz , et al. April 6, 2
2004-04-06
Manganese superoxide dismutase gene polymorphism for predicting cancer susceptibility
App 20020039733 - Lenz, Heinz-Josef ;   et al.
2002-04-04
Company Registrations
SEC0001699966Lenz Heinz Josef

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed